3 Hemophilia B Patients Report AMT-060 Gene Therapy Gave Them Normalcy
Three hemophilia B patients said they were able to lead a relatively normal life, including being more active and participating in sports, about three years after receiving the investigational gene therapy AMT-060 in a clinical trial. Their experiences were reported in the study, “The Patient…